Family Caregivers are the Heart of Alzheimer's and Dementia Care

...These statistics should make it glaringly obvious that family caregivers are indispensable to our nation as well as to the rest of the world. Without this so-called free care, global health systems would be in far worse trouble than they currently are. I am one of that army of caregivers. Over the span of two decades, I have provided primary care for a total of seven elders, four of whom had dementia of different types. Therefore, I know intimately the toll that years of caregiving for someone with dementia can take. Read the full article on HealthCentral to learn more about family caregivers and how they support elder care, dementia care, and Alzheimer's care: Carol is the Candid Caregiver MedicareFAQ – Medicare Resource Center Support a caregiver or jump-start discussion in support groups with real stories - for bulk orders of Minding Our Elders e-mail Carol                  Related StoriesNursing Homes Need Cater to Residents of All AgesChallenging Hobbies Help Maintain Brain HealthDealing With Embarrassment When Your Loved One Has Dementia 
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs

Related Links:

Conditions:   Mild Cognitive Impairment;   Dementia;   Intermittent Claudication Intervention:   Behavioral: Leg ischemia Sponsors:   Aristotle University Of Thessaloniki;   Greek Alzheimer's Association and Related Disorders Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s): Stacie Weninger, Bjorn Sperling, Lisa J. Bain, Maria C. Carillo
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
DiscussionThe Cognigram was well liked in waiting rooms of primary care settings. Assistance from a trained adult and clinic endorsement were keys to success. How the Cognigram performs in a geographically compact, population-dense global setting, such as Brooklyn with high vascular disease risk and a plethora of health disparities, is being tested.
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Because old age is the greatest risk factor for dementia, a successful therapy will require an understanding of the physiological changes that occur in the brain with aging. Here, two structurally distinct Alzheimer's disease (AD) drug candidates, CMS121 and J147, were used to identify a unique molecular pathway that is shared between the aging brain and AD. CMS121 and J147 reduced cognitive decline as well as metabolic and transcriptional markers of aging in the brain when administered to rapidly aging SAMP8 mice. Both compounds preserved mitochondrial homeostasis by regulating acetyl-coenzyme A (acetyl-CoA) metabolism. C...
Source: eLife - Category: Biomedical Science Tags: Neuroscience Source Type: research
Conclusion: FDG-PET-based visual and cortex ID classification has a good accuracy in predicting progression to dementia including AD in the prodromal aMCI phase. Absence of typical metabolic patterns on FDG-PET can play an important exclusionary role for progression to dementia. Vascular cognitive impairment with cerebral atrophy needs further studies to confirm and uncover potential mechanisms.
Source: Neurology India - Category: Neurology Authors: Source Type: research
More News: Alzheimer's | Brain | Cardiology | Dementia | Geriatrics | Heart | Learning | Medicare | Neurology | Primary Care | Statistics | Universities & Medical Training